Expand LN2 piping distribution, wedgewood suite k
Ended Awarded Last action
- Contract number
- 75N91019F00130
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,815,683
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $1,815,683.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $301,210 | |
| Other Administrative Action | $0 | |
| Original award | $1,514,473 |
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on May 22, 2019, for expansion of liquid nitrogen piping distribution at the Wedgewood Suite K facility, with a ceiling value of $1.8 million under a cost-plus-fixed-fee structure.
Place of performance is Frederick, MD. The order's ultimate completion date is September 30, 2020. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. and operates as a Federally Funded Research and Development Center contractor for NCI and the National Institutes of Health, providing biomedical research and facilities support services. In fiscal year 2020, the order generated $1.6 million in government-invoiced costs, which the prime self-performed without subcontractor engagement.
Quick answers
Who was awarded contract 75N91019F00130?
75N91019F00130 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on May 22, 2019.
How much is contract 75N91019F00130 worth?
The government has obligated $1,815,683 on 75N91019F00130.
Is contract 75N91019F00130 an order under another contract?
Yes. 75N91019F00130 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91019F00130 competed?
The extent of competition for 75N91019F00130 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award